ClinicalTrials.gg
RecruitingNCT07323862Updated Sep 2, 2026

Assessment of a Method to Improve Cochlear Implant Users' Speech Perception in Noisy Environments While Maintaining Their Ability to Determine Where a Sound Originates From

An interventional study of Modifying audio input for cochlear implant processor in Cochlear Implant Users, sponsored by University of Illinois at Urbana-Champaign. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-02.

Sponsored by University of Illinois at Urbana-Champaign · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Apr 2026; still recruiting 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to determine if a new algorithm can improve speech perception for cochlear implant users. The main questions it aims to answer [is/are]:

  • Does the algorithm improve speech perception in noisy environments?
  • Does the algorithm allow listeners to determine where a sound is coming from?

Participants will

  • Listen to and repeat sentences presented in the presence of noise
  • Indicate the location that sounds originated from
02

Conditions studied

  • Cochlear Implant Users

Keywords

  • Beamforming
  • Speech perception in noise
  • Localization
03

In context

Lead sponsor

University of Illinois at Urbana-Champaign is the lead sponsor of 191 studies on the registry; 29 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants must have bilateral cochlear implants from Cochlear or Advanced Bionics

Exclusion criteria

Exclusion Criteria:

  • Non-native English speakers
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
25 participants (estimated)

Study arms

  • Experimental
    Speech perception and localization with different beamformers

    Participants will listen to stimuli processed by different beamformer algorithms and repeat speech presented in noise and identify the location that sound originated from.

    Device: Modifying audio input for cochlear implant processor

Interventions

  • DeviceModifying audio input for cochlear implant processor

    Sound will be preprocessed with different beamformer algorithms and presented either through the auxiliary input port or via a streaming device to the participants' cochlear implant processor

06

What researchers measure

Primary outcomes

  1. Percent correct scores on speech perception in noise.

    The speech perception in noise test consists of lists of sentences in the presence of multi-talker babble or diffuse noise. The target location will vary across conditions. Participants will need to repeat back as much of the target sentence as they can.

    Time frame: Enrollment to 9 months

  2. Root mean square error for sound source localization

    The localization test will involve a target speaker in the presence of multi-speaker babble or diffuse noise. The virtual location of the sound sources will be manipulated and participants will need to indicate the location of the target speaker.

    Time frame: Enrollment to 9 months

07

Study locations

1 of 1 sites recruiting
  • Speech and Hearing Science Building
    Champaign, Illinois 61820, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The de-identified behavioral IPD from all experiments will be shared with the exception of pilot data.

Time frame: The data that will be shared will be made available no later than the time of an associated publication or one year after the end of the performance period. Per the policies of the Illinois Data Bank, data will be available for at least five years after it is first shared.

Access criteria: Data that will be shared will be stored in the Illinois Data Bank, a data repository managed by the University of Illinois. The data will be publicly available via the Illinois Data Bank.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07323862
Responsible party
Sponsor
First posted
Jan 7, 2026
Start date
Apr 27, 2026
Primary completion
Aug 31, 2027 (estimated)
Completion
Aug 31, 2027 (estimated)
Last update
Sep 2, 2026

Study contacts

Justin Aronoff, PhD
Contact
jaronoff@illinois.edu
217 244-2154

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion